VEGFA and female reproductive system neoplasm: In conclusion, due to high and specific accumulation observed in the subcutaneously growing KB-3-1 experimental cervix carcinoma tumors, [52Mn]Mn-DOTAGA-bevacizumab is a promising radiopharmaceutical in the imaging of VEGF-A positive gynecological tumors, in patient selection, and monitoring the efficacy of therapies targeting angiogenesis.